All Stories

  1. Effects of Dietary Sodium Modulation on Circulating Extracellular Vesicles
  2. To the Editor— DNA methylation and the potential role of extracellular vesicles in epilepsy-associated atrial fibrillation
  3. Extracellular vesicles from long COVID patients promote RUNX2-mediated cellular stress via dysregulated miR-204 and p53 pathway activation
  4. Extracellular vesicle signature is associated with cardio-metabolic improvement after bariatric surgery
  5. Machine learning-assisted assessment of extracellular vesicles can monitor cellular rejection after heart transplant
  6. Mitochondrial DNA released by senescent tumor cells enhances PMN-MDSC-driven immunosuppression through the cGAS-STING pathway
  7. Unveiling the role of tyrosine kinases in doxorubicin-induced cardiotoxicity and beyond
  8. Age- and sex-related variations in extracellular vesicle profiling for the assessment of cardiovascular risk: the EVaging index
  9. miR-24-3p secreted as extracellular vesicle cargo by cardiomyocytes inhibits fibrosis in human cardiac microtissues
  10. Extracellular vesicles from II trimester human amniotic fluid as paracrine conveyors counteracting oxidative stress
  11. A novel ionic model for matured and paced atrial-like human iPSC-CMs integrating I...
  12. Extracellular vesicles selective capture by peptide-functionalized hollow fiber membranes
  13. Targeting senescence induced by age or chemotherapy with a polyphenol-rich natural extract improves longevity and healthspan in mice
  14. Evolving Strategies for Extracellular Vesicles as Future Cardiac Therapeutics: From Macro- to Nano-Applications
  15. Comparison of assays measuring extracellular vesicle tissue factor in plasma samples: communication from the ISTH SSC Subcommittee on Vascular Biology
  16. Addressing Heterogeneity in Direct Analysis of Extracellular Vesicles and Their Analogs by Membrane Sensing Peptides as Pan‐Vesicular Affinity Probes
  17. Macrophage‐derived extracellular vesicles alter cardiac recovery and metabolism in a rat heart model of donation after circulatory death
  18. Injury minimization after myocardial infarction: focus on extracellular vesicles
  19. A novel ionic model for matured and paced atrial–like hiPSC–CMs integratingIKurandIKCacurrents
  20. Impact of Isolation Methods on Extracellular Vesicle Functionality In Vitro and In Vivo
  21. Intracoronary delivery of extracellular vesicles from human cardiac progenitor cells reduces infarct size in porcine acute myocardial infarction
  22. Particle profiling of EV‐lipoprotein mixtures by AFM nanomechanical imaging
  23. Cardiomyocyte-targeting exosomes from sulforaphane-treated fibroblasts affords cardioprotection in infarcted rats
  24. Extracellular Vesicles as Bridges Between Host Immune Cells and Graft Organ During Cellular Rejection
  25. A dynamic clamping approach using in silico IK1 current for discrimination of chamber-specific hiPSC-derived cardiomyocytes
  26. Plasma Extracellular Vesicles as Liquid Biopsy to Unravel the Molecular Mechanisms of Cardiac Reverse Remodeling Following Resynchronization Therapy?
  27. Fndc5/irisin-enriched extracellular vesicles: a new hormonal relay in the regular race against vascular ageing
  28. Identification of a serum and urine extracellular vesicle signature predicting renal outcome after kidney transplant
  29. Myosins and MyomiR Network in Patients with Obstructive Hypertrophic Cardiomyopathy
  30. Risk stratification of patients with SARS-CoV-2 by tissue factor expression in circulating extracellular vesicles
  31. Compositional profiling of EV-lipoprotein mixtures by AFM nanomechanical imaging
  32. Investigating the Paracrine Role of Perinatal Derivatives: Human Amniotic Fluid Stem Cell-Extracellular Vesicles Show Promising Transient Potential for Cardiomyocyte Renewal
  33. Good reasons for targeting SARS-CoV-2 by engineered extracellular vesicles
  34. Supervised and unsupervised learning to define the cardiovascular risk of patients according to an extracellular vesicle molecular signature
  35. Tau protein quantification in skin biopsies differentiates tauopathies from alpha-synucleinopathies
  36. Methods for the identification and characterization of extracellular vesicles in cardiovascular studies: from exosomes to microvesicles
  37. Stress-induced premature senescence is associated with a prolonged QT interval and recapitulates features of cardiac aging
  38. Extracellular Vesicle Surface Markers as a Diagnostic Tool in Transient Ischemic Attacks
  39. Characterization of Circulating Extracellular Vesicle Surface Antigens in Patients With Primary Aldosteronism
  40. Correction to: Cardiac Graft Assessment in the Era of Machine Perfusion: Current and Future Biomarkers
  41. Circulating extracellular vesicles are endowed with enhanced procoagulant activity in SARS-CoV-2 infection
  42. Structural and Electrophysiological Changes in a Model of Cardiotoxicity Induced by Anthracycline Combined With Trastuzumab
  43. Profiling Inflammatory Extracellular Vesicles in Plasma and Cerebrospinal Fluid: An Optimized Diagnostic Model for Parkinson’s Disease
  44. Cardiac Graft Assessment in the Era of Machine Perfusion: Current and Future Biomarkers
  45. A Changing Paradigm in Heart Transplantation: An Integrative Approach for Invasive and Non-Invasive Allograft Rejection Monitoring
  46. Circulating extracellular vesicles release oncogenic miR-424 in experimental models and patients with aggressive prostate cancer
  47. An exosomal-carried short periostin isoform induces cardiomyocyte proliferation
  48. Insights into therapeutic products, preclinical research models and clinical trials in cardiac regenerative and reparative medicine: where are we now and the way ahead. Current opinion paper of the ESC working group on cardiovascular regenerative and r...
  49. Circulating extracellular vesicles as non-invasive biomarker of rejection in heart transplant
  50. Sphingolipid composition of circulating extracellular vesicles after myocardial ischemia
  51. Role of cardiac progenitor cell-derived exosomes in a human model of ageing-induced cardiac dysfunction
  52. Systemic delivery of cardiac progenitor cell-derived exosomes ameliorate cardiac dysfunction induced by cancer drugs
  53. Immune profiling of plasma-derived extracellular vesicles identifies Parkinson disease
  54. An extracellular vesicle epitope profile is associated with acute myocardial infarction
  55. The swan song of dying cells
  56. Perioperative cardioprotection: back to bedside
  57. Message in a Bottle: Upgrading Cardiac Repair into Rejuvenation
  58. Mitochondrial and mitochondrial‐independent pathways of myocardial cell death during ischaemia and reperfusion injury
  59. Role of somatic cell sources in the maturation degree of human induced pluripotent stem cell-derived cardiomyocytes
  60. Ticagrelor Enhances Release of Anti-Hypoxic Cardiac Progenitor Cell-Derived Exosomes Through Increasing Cell Proliferation In Vitro
  61. Human Induced Pluripotent Stem Cells Derived from a Cardiac Somatic Source: Insights for an In-Vitro Cardiomyocyte Platform
  62. Inflammatory extracellular vesicles prompt heart dysfunction via TRL4-dependent NF-κB activation
  63. GMP-Grade Methods for Cardiac Progenitor Cells: Cell Bank Production and Quality Control
  64. EXODEVICE: Continuous Perfusion Large Scale Exosome Cultivation Bioreactor
  65. Reactivating endogenous mechanisms of cardiac regeneration via paracrine boosting using the human amniotic fluid stem cell secretome
  66. Flow Cytometric Analysis of Extracellular Vesicles from Cell-conditioned Media
  67. Flow Cytometric Analysis of Extracellular Vesicles from Cell-conditioned Media
  68. Exosomal Expression of CXCR4 Targets Cardioprotective Vesicles to Myocardial Infarction and Improves Outcome after Systemic Administration
  69. Circulating blood cells and extracellular vesicles in acute cardioprotection
  70. Exosomes From Human Cardiac Progenitor Cells for Therapeutic Applications: Development of a GMP-Grade Manufacturing Method
  71. Notch pathway activation enhances cardiosphere in vitro expansion
  72. ALDH1A3 Is the Key Isoform That Contributes to Aldehyde Dehydrogenase Activity and Affects in Vitro Proliferation in Cardiac Atrial Appendage Progenitor Cells
  73. The Bioactivities of Exosomes secreted by Cardiac Progenitor Cells
  74. Beneficial effects of exosomes secreted by cardiac-derived progenitor cells and other cell types in myocardial ischemia
  75. Angiogenic activity of exosomes isolated from human pericardial fluid
  76. Exosomes: Therapy delivery tools and biomarkers of diseases
  77. Intravenous administration of cardiac progenitor cell-derived exosomes protects against doxorubicin/trastuzumab-induced cardiac toxicity
  78. First Characterization of Human Amniotic Fluid Stem Cell Extracellular Vesicles as a Powerful Paracrine Tool Endowed with Regenerative Potential
  79. Roles of exosomes in cardioprotection
  80. Induced Pluripotent Stem (IPS) Cells to Assess the Cardioprotective and Proangiogenic Activities of Exosomes Secreted by Human Cardiac Progenitor Cells
  81. OUP accepted manuscript
  82. Epigenetic Regulation of Myocardial Homeostasis, Self-Regeneration and Senescence
  83. Combination of mi RNA 499 and mi RNA 133 Exerts a Synergic Effect on Cardiac Differentiation
  84. Exosomes for Intramyocardial Intercellular Communication
  85. Ranolazine prevents INaL enhancement and blunts myocardial remodelling in a model of pulmonary hypertension
  86. Exosomes act as intercellular carriers of proteins and miRNAs
  87. Altered functional differentiation of mesoangioblasts in a genetic myopathy
  88. Human Cardiospheres as a Source of Multipotent Stem and Progenitor Cells
  89. Prometheus’s heart: what lies beneath
  90. Prevention of Myocardial Remodeling by Chronic INaL Blockade in Pulmonary Hypertension
  91. Exosomes and Cardiomyocytes
  92. Isolation and Expansion of Adult Cardiac Stem/Progenitor Cells in the Form of Cardiospheres from Human Cardiac Biopsies and Murine Hearts
  93. Aberrant Functional Differentiation of Cardiac Precursors from a Dystrophic Mouse
  94. Induced pluripotent stem cells: progress towards a biomedical application
  95. A Brugada syndrome mutation (p.S216L) and its modulation by p.H558R polymorphism: standard and dynamic characterization
  96. Ferritin as a reporter gene for in vivo tracking of stem cells by 1.5-T cardiac MRI in a rat model of myocardial infarction
  97. Cardiac Cell Therapy: The Next (Re)Generation
  98. Evidence for the Existence of Resident Cardiac Stem Cells
  99. Bone marrow‐derived cells can acquire cardiac stem cells properties in damaged heart
  100. Caffeine-induced Ca2+ signaling as an index of cardiac progenitor cells differentiation
  101. Cardiospheres and tissue engineering for myocardial regeneration: potential for clinical application
  102. c-kit cardiac progenitor cells: What is their potential?
  103. New Perspectives to Repair a Broken Heart
  104. Differentiation of human adult cardiac stem cells exposed to extremely low-frequency electromagnetic fields
  105. Stem cells in the heart: What's the buzz all about? Part 2: Arrhythmic risks and clinical studies
  106. Stem cells in the heart: What's the buzz all about?—Part 1: Preclinical considerations
  107. Ion Cyclotron Resonance as a Tool in Regenerative Medicine
  108. Endogenous Cardiac Stem Cells
  109. Extremely low frequency magnetic field induces differentiation of the human cardiac stem cells
  110. Cardiac stem cells can be generated in damaged heart from bone marrow-derived cells
  111. The levels of GFP gene expression driven by regulatory regions of the mouse kit gene discriminate between HSC and progenitors
  112. Regenerative Potential of Cardiosphere-Derived Cells Expanded From Percutaneous Endomyocardial Biopsy Specimens
  113. Cardiac stem cells: isolation, expansion and experimental use for myocardial regeneration
  114. Cyclic Nucleotides and Neuroblastoma Differentiation
  115. Potential Role of Mycophenolate Mofetil in the Management of Neuroblastoma Patients
  116. Low levels of mycophenolic acid induce differentiation of human neuroblastoma cell lines